ENCAVIS AG/ DE0006095003 /
10.06.2024 17:00:17 | Изменение +0.01 | Объем сделки | Бид- | Предложение- | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
17.07EUR | +0.06% | 1,513 Оборот: 25,830.90 |
-Величина цены спроса: - | -Величина цены предложения: - | 2.75 млрдEUR | - | 51.70 |
GlobeNewswire
8:20
Himax to Make Strategic Investment in FOCI Private Placement Financing; Companies to Unite FOCI’s Wo...
GlobeNewswire
8:15
ROHM’s New TRCDRIVE pack™ with 2-in-1 SiC Molded Module: Significantly Reduces the Size of Electric ...
GlobeNewswire
8:00
FTI Consulting Appoints Senior Forensic Expert Dr. Stefan Heissner to the Forensic and Litigation Co...
GlobeNewswire
8:00
Bedford Metals Engages CanExplor Management for Satellite Survey of Ubiquity Lake Uranium Project
GlobeNewswire
8:00
Viridien Joins Forces with Ranch Computing to Supercharge the Digital Media Landscape
GlobeNewswire
7:45
GRITSTONE BIO, INC. (NASDAQ: GRTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securitie...
GlobeNewswire
7:00
Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy
GlobeNewswire
7:00
Feutune Light Acquisition Corporation Announces that It Will Adjourn the Special Meeting of Stockhol...
GlobeNewswire
7:00
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPi...
GlobeNewswire
7:00
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
GlobeNewswire
6:00
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница